National Research Council Canada-NRC

National Research Council Canada-NRC
Zymeworks Inc.

Zymeworks Inc.

March 17, 2014 11:03 ET

Media Advisory: NRC and Zymeworks Announce New Partnership for the Development of Ground-Breaking Therapies to Fight Cancer

TORONTO, ONTARIO--(Marketwired - March 17, 2014) - The National Research Council of Canada (NRC) and Zymeworks Inc., a leading Canadian biotherapeutics company, will announce tomorrow a strategic collaborative agreement focused on developing innovative therapies for the fight against cancer.

Dr. Roman Szumski, Vice President of Life Sciences at the National Research Council; Dr. Ali Tehrani, President and Chief Executive Officer of Zymeworks; and, Dr. Julie Ducharme, General Manager of Human Health Therapeutics at NRC, will be available for interviews.

Photo Opportunity

Two microscopes will be on display for guests and media to observe early stage and advanced stage cancer cells which, even to the untrained eye, look extremely different.

Date: Tuesday, March 18, 2014
Time: 10:30 a.m. ET
Location: BioTransfer2014
Hyatt Regency Toronto, Room King I
370 King Street West
Toronto, Ontario M5V 1J9

Contact Information

  • Media Relations Team
    National Research Council of Canada
    1-855-282-1637 (24/7
    Twitter: @nrc_cnrc

    David Poon
    Director, External R&D and Alliances
    Zymeworks Inc.